⌘K

Login Start Free

Home/Filings/4/0001144204-17-004428

4//SEC Filing

IMMUNE PHARMACEUTICALS INC 4

Accession 0001144204-17-004428

CIK 0001208261operating

View on SEC.gov Company Profile

Filed

Jan 26, 7:00 PM ET

Accepted

Jan 27, 7:14 PM ET

Size

5.5 KB

Accession

0001144204-17-004428

Insider Transaction Report

Form 4

Period: 2017-01-25

IMMUNE PHARMACEUTICALS INCIMNP

Director

Transactions

Award
Stock Option
2017-01-25+500,000→ 640,000 total
Exercise: $0.20From: 2017-01-25Exp: 2027-01-25→ Common Stock (500,000 underlying)

Footnotes (1)

[F1]The stock options shall vest in equal quarterly installments over a one-year period from the date of grant.

Documents

1 file

4
v457808_form4.xmlPrimary
FORM 4

Issuer

IMMUNE PHARMACEUTICALS INC

CIK 0001208261

Entity typeoperating

IncorporatedDE

Related Parties

1

filerCIK 0001208261

Filing Metadata

Form type: 4
Filed: Jan 26, 7:00 PM ET
Accepted: Jan 27, 7:14 PM ET
Size: 5.5 KB

View on SEC.gov